(S1 (S (S (NP (NN RhoA-mediated) (NN Phospholipase) (NN D1) (NN signaling)) (VP (VBZ is) (RB not) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (NN stress) (NNS fibers)) (CC and) (NP (JJ focal) (NNS adhesions))))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ small) (NN GTPase) (NN RhoA)) (VP (VBZ regulates) (NP (NP (DT a) (JJ wide) (NN spectrum)) (PP (IN of) (NP (NP (JJ cellular) (NNS functions)) (PP (VBG including) (NP (NP (NN transformation)) (CC and) (NP (JJ cytoskeletal) (NN reorganization))))))))) (. .)))
(S1 (S (S (S (NP (NP (DT A) (JJ large) (NN number)) (PP (IN of) (NP (NNS proteins)))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (PP (IN as) (NP (NP (NNS targets)) (PP (IN of) (NP (NN RhoA))))))))) (, ,) (CC but) (S (NP (NP (PRP$ their) (JJ specific) (NNS roles)) (PP (IN in) (NP (DT these) (NNS processes)))) (VP (VBP are) (RB not) (ADJP (JJ clear))))) (. .)))
(S1 (S (S (NP (NP (NN Phospholipase) (NN D)) (PRN (-LRB- -LRB-) (NP (NN PLD)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (NP (CD one) (JJ such) (NN target)) (ADVP (NP (JJ several) (NNS years)) (RB ago)))))))) (: ;) (S (NP (NP (ADJP (RBR more) (JJ recent)) (NN work)) (PP (IN from) (NP (NP (PRP$ our) (NN laboratory)) (CC and) (NP (NNS others))))) (VP (VBZ has) (VP (VBN demonstrated) (SBAR (IN that) (S (PP (IN of) (NP (DT the) (CD two) (JJ mammalian) (NN PLD) (NNS isozymes))) (, ,) (S (NP (NP (NN PLD1)) (CONJP (CC but) (RB not)) (NP (NN PLD2))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN RhoA)))))) (CC and) (S (NP (DT this) (NN activation)) (VP (VBZ proceeds) (PP (IN through) (NP (NP (JJ direct) (NN binding)) (ADVP (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo)))))))))))) (. .)))
(S1 (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (S (VP (VBG using) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NN RhoA) (NNS mutants)))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN defined) (NP (NP (DT a) (JJ PLD1-specific) (VBG interacting) (NN site)) (PP (IN on) (NP (NN RhoA))) (VP (VBN composed) (PP (IN of) (NP (NP (DT the) (NNS residues) (NP (NP (NN Asn41)) (, ,) (NP (NN Trp58)) (CC and) (NP (NN Asp76)))) (, ,) (S (VP (VBG using) (NP (NP (DT the) (NN yeast) (JJ two-hybrid) (NN system)) (, ,) (NP (NN co-immunoprecipitation)) (, ,) (CC and) (NP (DT a) (NN PLD) (ADJP (FW in) (FW vivo)) (NN assay))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NNS results)) (ADVP (RB further)) (VP (VBP substantiate) (NP (PRP$ our) (JJ previous) (NN finding) (SBAR (IN that) (S (NP (NN RhoA)) (VP (VBZ activates) (NP (NN PLD1)) (PP (IN through) (NP (JJ direct) (NN interaction))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS mutants)) (VP (VBD were) (ADVP (RB then)) (VP (VBN used) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN PLD1))) (PP (IN in) (NP (NP (DT the) (JJ cytoskeletal) (NN reorganization)) (VP (VBN stimulated) (PP (IN by) (NP (NN RhoA) (NN signaling))))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NN PLD1)) (VP (VBZ is) (RB not) (VP (VBN required) (PP (IN for) (NP (DT the) (NN RhoA-mediated) (NN stress) (NN fiber) (CC and) (JJ focal) (NN adhesion) (NN formation))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (NN importance)) (PP (IN of) (NP (NN PLD1) (NN signaling))) (PP (IN in) (NP (NN RhoA-mediated) (JJ cytoskeletal) (NN reorganization)))))) (VP (VBZ is) (VP (ADVP (RB further)) (VBN supported) (PP (IN by) (NP (DT the) (NN observation) (SBAR (IN that) (S (NP (NP (NP (NN PLD1) (NN depletion)) (VP (VBG using) (NP (DT an) (NN shRNA) (NN approach)))) (CC and) (NP (NP (JJ tetracycline-induced) (NN overexpression)) (PP (IN of) (NP (NP (DT the) (JJ wild-type)) (CC and) (NP (NP (DT the) (ADJP (RB catalytically) (JJ inactive)) (NN mutant)) (PP (IN of) (NP (NN PLD1)))))) (PP (IN in) (NP (JJ stable) (NN cell) (NNS lines))))) (VP (VBP do) (RB not) (VP (VB alter) (NP (NN stress) (NN fiber) (CC and) (JJ focal) (NN adhesion) (NN formation))))))))))) (. .)))
